Reumuth Mary's Form 4 filing
KALA BIO, Inc. (KALA) · filed Oct 24, 2025
- Accession no.
- 0001710969-25-000003
- Filed
- Oct 24, 2025
- Trade date
- Oct 22-23, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $27.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reumuth MaryCIK 0001710969 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | Common Stock | SSaleDisposed | −32,230 | $0.83 | −$26,750.9 | 29,873 | Direct | |
| Oct 23, 2025 | Common Stock | SSaleDisposed | −967 | $0.82 | −$792.94 | 28,906 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.